Cancer Market Research Reports & Industry Analysis
Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
... of brain cancer; five-year diagnosed prevalent cases; diagnosed incident cases of brain cancer type; and diagnosed incident cases of brain cancer with associated biomarkers. The brain cancer epidemiology forecast report ...
Oct, 2018 32 pages... Market Share by Application of Prostate Cancer Diagnostics. Chapter 5: Production Volume, Price, Gross Margin, and Revenue ($) of Prostate Cancer Diagnostics by Regions (2013-2018). Chapter 6: Prostate Cancer Diagnostics Production, Consumption, Export ...
Nov, 2018 114 pages... panorama of industrial development and characteristics of the Breast Cancer market. The Breast Cancer market can be split based on product types, major ... Product Introduction, Company Profiles, Market Distribution Status by Players of Breast Cancer. Chapter 9: Breast Cancer Market Analysis and Forecast by Type ...
Nov, 2018 105 pages... for Monoclonal Antibodies for Cancer Treatment Global Cancer Monoclonal Antibodies Market Overview Global Cancer Monoclonal Antibodies Pipeline by Phase & Indication Global Cancer Monoclonal Antibodies Pipeline: 697 mAb Marketed Cancer Monoclonal Antibodies: 60 Global Cancer Monoclonal Antibodies Market ...
Nov, 2018 1100 pages... for the lung cancer therapeutics market, and information pertaining to leading lung cancer market players, their marketed products, pipeline products and product patent expirations Detailed company profiles of major manufacturers of oncology products, including ...
Nov, 2018 161 pages... (MEA) cancer screening market is growing at a very slow rate. The MEA market is projected to reach USD 50.61 Bn by 2023, at a compound annual growth rate (CAGR) of 11.5% during the forecast period (2018-2023).The ...
Sep, 2018 90 pagesCancer screening market in the U.S.A. The United States Of America (U.S.A.) is leading the cancer screening market. The rising incidence of cancer along with growing awareness regarding prevention of diseases and diagnosis is a ...
Sep, 2018 90 pagesCancer screening market in the U.K. The United Kingdom (U.K.) stands next to the United States of America (U.S.A.) in coming up with latest technologies to combat the spread of cancer. The cancer screening market in the U.K. is expected to reach USD ...
Sep, 2018 90 pages... in the report? 1. Overview of the cancer screening market in India. 2. Market drivers and challenges in the cancer screening market in India. 3. Market trends in the cancer screening market in India. 4. Historical, current and forecasted market size data for segments ...
Sep, 2018 90 pages... in the report? 1. Overview of the cancer screening market in China. 2. Market drivers and challenges in the cancer screening market in China. 3. Market trends in the cancer screening market in China. 4. Historical, current and forecasted market size data for segments ...
Sep, 2018 90 pages... ? 1. Overview of the North America cancer screening market. 2. Market drivers and challenges in the North America cancer screening market. 3. Market trends in the North America cancer screening market. 4. Historical, current and forecasted market size data for the North America market segmentation based ...
Sep, 2018 90 pages... ? 1. Overview of the Latin America cancer screening market. 2. Market drivers and challenges in the Latin America cancer screening market. 3. Market trends in the Latin America cancer screening market. 4. Historical, current and forecasted market size data for the Latin America market segmentation based ...
Sep, 2018 90 pages... market leading the cancer screening market. The market is forecasted to grow at a compound annual growth rate of (CAGR) of 8.1% resulting in an annual revenue of USD 22.43 Bn during the forecast period (2018-2023 ...
Sep, 2018 90 pages... global cancer screening market is expected to grow at a compound annual growth rate (CAGR) of 11% during the forecast period. The market is expected to return a revenue of USD 152.10 Bn by 2023. The cancer screening market ...
Sep, 2018 100 pages... ? 1. Overview of the Asia-Pacific cancer screening market. 2. Market drivers and challenges in Asia-Pacific cancer screening market. 3. Market trends in the Asia-Pacific cancer screening market. 4. Historical, current and forecasted market size data for the Asia-Pacific market segmentation based on type ...
Sep, 2018 90 pagesCancer Immunotherapy Market by Type (Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy), Application ( ...
Nov, 2018 173 pages... of PARP Inhibitors in Oncology: Background, mechanism of action, and clinical development of PARP inhibitors. Epidemiology Analysis: Which current and future disease spaces are relevant to PARP inhibitors. Marketed PARP Inhibitors: How ...
Sep, 2018 116 pages... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...
Aug, 2018 427 pagesSquamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H2, 2018 SUMMARY GlobalData's clinical trial report, “Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H2, 2018' provides an overview of Squamous Non-Small Cell Lung Cancer clinical trials scenario. This report provides top ...
Aug, 2018 252 pages... - Overview of Market Access, Pricing and Reimbursement - What is market access and what are the key concepts and components for pharmaceutical market access of oncology medicines in Europe. Market Access, Pricing and Reimbursement in the ...
Sep, 2018 162 pagesBiosimilars in Oncology SUMMARY Recent trends in drug ... of each key biosimilars market Outline of important indications for oncology biosimilars Review of key biosimilar developers and their ... potential and current regulatory outlook shaping the oncology biosimilars landscape in key markets. Develop strategies by ...
Aug, 2018 154 pagesThis report provides an overview of the US cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Contains 40 pages and 7 tables
Sep, 2018 40 pagesThis report provides an overview of the U.K. cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Contains 16 pages and 4 tables
Sep, 2018 16 pagesThis report provides an overview of the Spanish cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Contains 16 pages and 7 tables
Sep, 2018 16 pagesThis report provides an overview of the Japanese cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Contains 23 pages and 6 tables
Sep, 2018 23 pagesThis report provides an overview of the Italian cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Contains 18 pages and 5 tables
Sep, 2018 18 pagesThis report provides an overview of the German cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Contains 25 pages and 7 tables
Sep, 2018 25 pagesThis report provides an overview of the French cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Contains 25 pages and 7 tables
Sep, 2018 25 pagesDigital Landscape: Breast Cancer SUMMARY The 'Digital Landscape: Breast Cancer', report analyzes digital activities undertaken by pharma in support of therapies for breast cancer. KEY HIGHLIGHTS US Patients: Strong digital support for US breast cancer patients in the US, particularly ...
Sep, 2018 155 pages... chemotherapy or any other treatments. The regional analysis of Global Oncology Nutrition Market is considered for the key regions such as Asia ... . Target Audience of the Global Oncology Nutrition Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture ...
Sep, 2018 120 pages... . Market Segmentation: Global Eye cancer market is segmented on the basis of regional outlook and following segments: 1. Global Eye cancer Market Research and Analysis, By Types 2. Global Eye cancer Market Research and Analysis, By Treatment 3. Global Eye cancer Market Research ...
Aug, 2018... for cervical cancer and provenge for prostate cancer have already entered the market. Both the vaccines are therapeutic vaccines which have shown excellent outcome in the clinical trials. The ...
Sep, 2018 700 pages... involved in therapeutic development for pancreatic and bile duct cancer, and features dormant and discontinued products. Pancreatic cancer is a disease in which malignant (cancer) cells are found in the ...
Aug, 2018 385 pages... forecast period By therapy type, the China anti-cancer drugs market is segmented into chemotherapy, targeted therapy, hormonal therapy and others. Chemotherapy and targeted therapy together held the major share of China cancer drugs market. Company ...
Aug, 2018... organizations & biotechnology. Renub Research latest study report “Breast Cancer Screening Market, Population, By Screening Tests [Mammography, Magnetic Resonance Imaging (MRI) & Ultrasound] By Countries (United States, Canada, United Kingdom, France ...
Aug, 2018Global Cancer Immunotherapies Market to 2024 - Increased Uptake of Immune Checkpoint Inhibitors Driving Growth, Supported by a Large, Robust Pipeline SUMMARY Cancer immunotherapy, which can predominantly be classed as a form of targeted therapy ...
Jul, 2018 215 pagesFrontier Pharma: Breast Cancer - First-in-Class Innovation Underlies Immunotherapeutic Potential and Pipeline Diversification for Late-Stage Breast Cancer SUMMARY Breast cancer remains ... clinical need in the breast cancer treatment algorithm. The treatment algorithm for breast cancer focuses on two main themes ...
Jul, 2018 122 pages... presents strategic analyses of leading current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know ...
Aug, 2018 104 pages... Novel Drug Delivery Systems (NDDS) in Cancer Therapy market size will grow from XX Million in 2017 to XX Million by 2023 ... , and the market size is projected from 2018 to 2023. The world is witnessing a continuous rise ... detail. Data and information by manufacturer, by region, by type, by application and etc, and ...
Aug, 2018 153 pages... to the growth of the global market for in-vitro colorectal cancer screening testing. By Market Players: Abbott ... 2012 to 2017 and forecast data from 2018 to 2023. The growth factors of the market is ... explained in detail. Data and information by manufacturer, by region, by type, by application and etc, and custom ...
Aug, 2018 157 pages... , and the market size is projected from 2018 to 2023. According to the World Health Organization (WHO), cervical cancer is the second most commonly prevalent ... of the market are explained in detail. Data and information by manufacturer, by region, by type, by application and etc, and custom research can be added ...
Aug, 2018 131 pages... . MARKET SEGMENTATION: Global Cancer gene therapy market is segmented on the basis of regional outlook and following segments: Global Cancer gene therapy Market Research and Analysis, By Therapy Global Cancer gene therapy Market Research and Analysis, By End Users Global Cancer gene therapy Market Research ...
Jul, 2018Pancreatic Cancer: Opportunity Analysis and Forecast to 2026 SUMMARY Pancreatic cancer is set to become the second leading cause of cancer-related deaths in the US in 2020 after lung cancer ... and implications for the pancreatic cancer therapeutics market. Pipeline analysis: comprehensive data assessing emerging ...
Apr, 2018 225 pagesReport Package Immuno-Oncology: Inhibitory and Stimulatory Immunomodulators This product consists of four reports in pdf ... include compilations of currently active projects in research and development of immunomodulators in immuno-oncology. In addition, each report lists company-specific R&D pipelines of ...
Jul, 2018 455 pages... Tests are divided into Occult blood and DNA tests. Colorectal cancer diagnostic market is expected to grow in future due to increasing disposable ... quality of screening process and dearth of expertise. The report “Colorectal Cancer Diagnostics Market with Focus on DNA-based Tests: Industry Analysis & Outlook ( ...
Jul, 2018 86 pagesThe global colorectal cancer (CRC) drugs market size is expected to reach ... some of the unmet needs of the colorectal cancer (CRC) market. If approved, Array Biopharma’s ... drugs Roche led the colorectal cancer industrial setting in 2016 due to growing usage of Avastin. Avastin was the highest revenue-generating CRC ...
Jun, 2018 99 pagesThe global liver cancer drugs market size is expected to be valued at USD 1.47 billion by 2022, as per a new report by Grand ... of 19.4% during the forecast period. The growth of liver cancer market is largely driven by factors such as availability of novel drugs, presence of strong pipeline, and rising public ...
Jun, 2018 92 pages... kidney cancer drugs market size is expected to be valued at USD 6.3 billion by 2022, as per a new report by Grand View Research, Inc., registering a CAGR of 5.4% during the forecast period. Market ... hand, surge in kidney cancer screening is a key driver in markets such as EU Emerging markets in Asia Pacific and ...
Jun, 2018 99 pages... North America’s country (United State and Canada) which provides a complete country-wise analysis of North America Cervical Cancer Screening Market, Population and Mortality. Cervical Cancer Diagnostic Market & Population Pap Smear Tests Market HPV DNA Tests Market Cervical Cancer Mortality Population United ...
Jul, 2018... on the cost and reimbursement of novel cancer gene therapies. SCOPE GlobalData’s Gene Therapy in Oncology combines KOL and payer insight with in-house analyst ... what are the currently marketed gene therapies in the oncology space in the 8MM. Clinical Development of Gene Therapies in Oncology: What are the late ...
Jun, 2018 145 pages